Visible light mediated PVA-tyramine hydrogels for covalent incorporation and tailorable release of functional growth factors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Visible light mediated PVA-tyramine hydrogels for covalent incorporation and tailorable release of functional growth factors

Published:2020 Issue:18 Volume:8 Page:5005-5019
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Atienza-Roca Pau¹²³⁴,Kieser David C.¹²³⁴^ORCID,Cui Xiaolin¹²³⁴^ORCID,Bathish Boushra¹²³⁴,Ramaswamy Yogambha⁵⁶⁷⁸,Hooper Gary J.¹²³⁴^ORCID,Clarkson Andrew N.⁹¹⁰¹¹¹²⁴^ORCID,Rnjak-Kovacina Jelena¹³¹⁴¹⁵⁸^ORCID,Martens Penny J.¹³¹⁴¹⁵⁸^ORCID,Wise Lyn M.¹⁶¹¹⁴^ORCID,Woodfield Tim B. F.¹²³⁴^ORCID,Lim Khoon S.¹²³⁴^ORCID

Affiliation:

1. Department of Orthopaedic Surgery

2. University of Otago Christchurch

3. Christchurch 8011

4. New Zealand

5. School of Biomedical Engineering

6. University of Sydney

7. Sydney 2006

8. Australia

9. Department of Anatomy

10. Brain Health Research Centre and Brain Research New Zealand

11. University of Otago

12. Dunedin 9054

13. Graduate School of Biomedical Engineering

14. UNSW Sydney

15. Sydney 2052

16. Department of Pharmacology and Toxicology

Abstract

PVA-Tyr hydrogel facilitated covalent incorporation can control release of pristine growth factors while retaining their native bioactivity.

Funder

Canterbury Medical Research Foundation

University of Otago

Ministry of Business, Innovation and Employment

Royal Society of New Zealand

National Heart Foundation of Australia

Health Research Council of New Zealand

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00603C

Reference81 articles.

1. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers

2. Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site

3. Local application of recombinant human fibroblast growth factor-2 on bone repair: A dose–escalation prospective trial on patients with osteotomy

4. Endogenous regeneration: Engineering growth factors for stroke

5. FDA , Safety Warning on Becaplermin in Regranex , 2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial progenitor cells for fabrication of engineered vascular units and angiogenesis induction;Cell Proliferation;2024-07-25

2. Biodegradable Tyramine Functional Gelatin/6 Arms-PLA Inks Compatible with 3D Two Photon-Polymerization Printing and Meniscus Tissue Regeneration;Biomacromolecules;2024-07-23

3. Photo-/thermo-responsive bioink for improved printability in extrusion-based bioprinting;Materials Today Bio;2024-04

4. Photocrosslinked Silk Fibroin Microgel Scaffolds for Biomedical Applications;Advanced Functional Materials;2024-01-18

5. Pristine gelatin incorporation as a strategy to enhance the biofunctionality of poly(vinyl alcohol)-based hydrogels for tissue engineering applications;Biomaterials Science;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3